ORBIMED ADVISORS LLC 13D and 13G filings for Sionna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:47 pm Purchase | 2025-02-10 | 13D | Sionna Therapeutics, Inc. SION | ORBIMED ADVISORS LLC | 3,704,959 8.400% | 3,704,959 (New Position) | Filing |